Khyati B. Rohit, Gunvant H. Yeola, Kalyani P. Nishane, Amol H. Waghmare, D. G. Dipankar
firstname.lastname@example.org , email@example.com , firstname.lastname@example.org , email@example.com , firstname.lastname@example.org
Khyati B. Rohit1, Gunvant H. Yeola2, Kalyani P. Nishane3, Amol H. Waghmare4, D. G. Dipankar5
1Assistant Professor, Department of Kayachikitsa, Global Institute of Ayurveda and Hospital, Rajkot, Gujrat 360020 and Former P.G. Scholar, Department of Kayachikitsa, Dr. D. Y. Patil College of Ayurved and Research Centre, Pimpri, Pune of Dr. D. Y. Patil Vidyapeeth, Pune (Deemed to be University).
2Principal, Professor and HOD, Department of Kayachikitsa, Dr. D. Y. Patil College of Ayurved and Research Centre, Pimpri, Pune of Dr. D. Y. Patil Vidyapeeth, Pune (Deemed to be University).
3Assistant Professor, Department of Kayachikitsa, Prabuddh Ayurvedic Medical College Hospital and Research Centre, Lucknow, Uttar Pradesh and Former P.G. Scholar, Department of Kayachikitsa, Dr. D. Y. Patil College of Ayurved and Research Centre, Pimpri, Pune of Dr. D. Y. Patil Vidyapeeth, Pune (Deemed to be University).
4Associate Professor, Department of RS and BK, Dr. D. Y. Patil College of Ayurved and
Volume - 15,
Issue - 3,
Year - 2022
Hyperlipidaemia is one such lifestyle disorder which is identified as an impending risk factor for many diseases like hypertension, metabolic syndrome, coronary artery disease (CAD) and cerebrovascular diseases (CVD). In Hyperlipidaemia levels of lipoproteins i.e. (cholesterol, triglycerides, or both) are raised in the plasma, which can be co-related to elevated Sneha or Meda Dhatu in the body. As drugs used in modern medicine viz. statins, fibrates etc. to treat hyperlipidaemia has several adverse effects such as myopathy, potential elevation in serum transaminase levels leading to hepatic damage, nausea or vomiting, bowel upset, multiple joint pain etc. Hence, it is very much necessary to have definite and harmless solution to this problem. Apatarpan is the treatment advocated in ayurved for Santarpanjanya Vyadhis and Hyperlipidaemia is one among this group of disease. Taking into consideration all the treatment modalities in Ayurveda, Rasarakta Pachak Ghanavati was given as a line of treatment in Hyperlipidaemia. Methods - 60 patients of Hyperlipidaemia as per the objective criteria of range for lipid profile mentioned in American Journal of Lifestyle Medicine were randomly selected from OPD and IPD of Dr. D. Y. Patil College of Ayurved and Research centre, Pimpri, Pune. Group A (n=30) patients were treated with Rasarakta Pachak Ghanavati (500mg) 2 tabs twice in a day after food for 30 days and Group B (n=30) patients were treated with Tab Atorvastatin (10mg) 1 tab once in a day after food for 30 days. Result- Rasarakta Pachak Ghanavati group showed marked improvement on Serum Total Cholesterol and Serum LDL – Cholesterol and moderate improvement on Serum Triglycerides and Serum HDL – Cholesterol parameters of lipid profile. While Tab Atorvastatin group showed marked improvement on almost all the parameters of lipid profile.
Cite this article:
Khyati B. Rohit, Gunvant H. Yeola, Kalyani P. Nishane, Amol H. Waghmare, D. G. Dipankar. Clinical Evaluation of efficacy of Rasarakta pachak Ghanavati in Hyperlipidaemia (Rasagat sneha vriddhi). Research Journal of Pharmacy and Technology. 2022; 15(3):971-5. doi: 10.52711/0974-360X.2022.00162
Khyati B. Rohit, Gunvant H. Yeola, Kalyani P. Nishane, Amol H. Waghmare, D. G. Dipankar. Clinical Evaluation of efficacy of Rasarakta pachak Ghanavati in Hyperlipidaemia (Rasagat sneha vriddhi). Research Journal of Pharmacy and Technology. 2022; 15(3):971-5. doi: 10.52711/0974-360X.2022.00162 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-3-5
1. Kasper Hauser, Braunwald Logo, Frauci Jameson, Harrison’s Principles of Internal Medicine (Vol II), Edition – 16th, 2002
2. Manjiri Arun Nadkarni et al Randomized placebo-controlled trial of Mustadi Ghanavati in hyperlipidemia Ayu. 2010 Jul;31(3):287-93. doi: 10.4103/0974-8520.77150.
3. G Shobana, G Sivaelango, P. Kumaravel. Evaluation of antihyperlipidaemic effect of Macrotyloma uniflorum seed extract in experimental hyperlipidaemia. Research J. Pharm. and Tech. 5(3): Mar.2012; Page 353-356.
4. Kalaivanan S, Sarumathy S, Anisha Ebens J, et al Clinical Assessment and Comparison of Lipid Profiles among Coronary Artery Disease and type 2 Diabetes Mellitus Patients receiving Statin Therapy. Research J. Pharm. and Tech. 2017; 10(1): 18-20. doi: 10.5958/0974-360X.2017.00005.1
5. Tayseer Shamran Al-Deresawi, Akmam Ali Habeeb the side effects of the Atorvastatin on liver of Hyperlipidemia Patients. Research J. Pharm. and Tech 2019; 12(9):4310-4312. doi: 10.5958/0974-360X.2019.00741.8
6. C. Dwarkanath, Digestion and Metabolism in Ayurveda, Chaukhambha Krishnadas Academy, Varanasi, Edition – reprint-2010.
7. Acharya Vidyadhar Shukla, Prof. Ravi Dutt Tripathi, Charak Samhita of Agnivesha (Volume II), edited with ‘Vaidyamanorama’ Hindi Commentary Chaukhamba Sanskrit Pratishthan Delhi, Reprinted- 2009.
8. Dr. Brahmanand Tripathi editor Charak Samhita Chiktisha Sthan 14/32 Varanasi Chaukhamba Surbharati Prakashan (2007).
9. Sunkara Mrunal Chaithanya, Mukthinuthalapati Mathrusri Annapurna. Stability indicating RP-UPLC method for the simultaneous determination of Atorvastatin and Amlodipine. Research J. Pharm. and Tech 2019; 12(10):4867-4872. doi: 10.5958/0974-360X.2019.00843.6
10. Urvi S Shah, KN Patel. Protective effects of Strychnos potatorum Linn. seeds extract in hyperlipidemic rat model. Research J. Pharmacology and Pharmacodynamics. 2012; 4(4): 213-217.
11. K.D. Tripathi, Essentials of Medical Pharmacology, Jaypee Brothers Medical Publishers (P) LTD, Edition – 6th reprint-2010.
12. Vaidya V.M.Gogte, Ayurvedic Pharmacology and Therapeutic uses of Medicinal Plants Dravyaguna Vignyan, Chaukhambha Publication New Delhi, Edition: Reprint 2012.
13. Virani Paras, Virani Kinjal. A Review on Irbesartan Co-administered with Atorvastatin for the Treatment of Cardiac Risk. Asian J. Pharm. Res. 6(1): January -March 2016; Page 39-44. doi: 10.5958/2231-5691.2016.00007.1
14. Ragavi R, Saritha A Surendran. Commiphora mukul: An Overview. Research J. Pharm. and Tech 2018; 11(7): 3205-3208. doi: 10.5958/0974-360X.2018.00589.9
15. Anis Fathima. A. G, Vara Prasanna Rao, P. Shanmugasundaram. A Prospective Observational Study on Drug Utilization Evaluation of Atorvastatin in Tertiary Care Hospital. Research J. Pharm. and Tech. 2017; 10(7): 2183-2188. doi: 10.5958/0974-360X.2017.00385.7
16. Preeti Tiwari. Antihyperlipidemic potential of Balarishta prepared by traditional and modern methods in high fat diet induced Hyperlipidemic rats. Asian J. Res. Pharm. 4(1): Jan–Mar.2014; Page 07-11
17. Preeti Tiwari. Antimicrobial Activity of Amritarishta Prepared by Traditional and Modern Methods. Asian J. Pharm. Res. 4(2): April-June 2014; Page 114-116.